Literature DB >> 15532759

A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension.

D Badenhorst, C Anamourlis, M Gibbs, M Maseko, O Osadchii, A J Woodiwiss, G R Norton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15532759

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  1 in total

1.  Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.

Authors:  Walid Mokni; Thérèse Keravis; Nelly Etienne-Selloum; Alison Walter; Modou O Kane; Valérie B Schini-Kerth; Claire Lugnier
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.